N/A N=543 Randomized Quadruple-blind Prevention

Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms

Common Cold

Bottom Line

View on ClinicalTrials.gov: NCT00778648 ↗

Enrolled (actual)

543

Serious AEs

0.0%

Results posted

Oct 2010

Primary outcome: Primary: Number of Days With at Least Moderate (i.e. Moderate or Severe) Common Cold Symptoms. — 7.6; 9.5 Number of days — p=0.023

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Juice Plus (Dietary_supplement); Placebo (Dietary_supplement)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Charite University, Berlin, Germany
Primary completion: Jul 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Days With at Least Moderate (i.e. Moderate or Severe) Common Cold Symptoms.	7.6; 9.5	0.023 sig
SECONDARY Secondary Endpoints of This Study Are Mean Health-related Quality of Life, Mean Common Cold Related Total Costs, Direct and Indirect (Productivity Loss) Costs	—	—

Summary

The primary objective of this study is to determine the effect of an encapsulated juice powder concentrate on the number of days with at least moderate common cold symptoms over winter time.

Eligibility Criteria

Inclusion Criteria

Female or male, 18-65 years of age.
Able and willing to take the active or placebo capsules over the whole study period.
Health care professionals with essential patient contact (physicians, nurses, physiotherapists, etc) in Berlin, Germany.
Written informed consent.

Exclusion Criteria

Known or suspected hypersensitivity or allergy to one of the ingredients of Juice Plus+®.
Refusal to stop intake of additional vitamin supplements during study.
Pregnancy or Lactation.
Alcohol addiction, drug abuse or any other condition considered by the investigator to interfere with study procedures.
Language limitations regarding interviews and questionnaires.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00778648). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.